Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment.

MLA

Liu, Li, et al. “Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment.” Cancers, vol. 14, no. 17, Sept. 2022, p. 4208. EBSCOhost, https://doi.org/10.3390/cancers14174208.

APA

Liu, L., Schuetze, R., Gerberich, J. L., Lopez, R., Odutola, S. O., Tanpure, R. P., Charlton-Sevcik, A. K., Tidmore, J. K., Taylor, E. A.-S., Kapur, P., Hammers, H., Trawick, M. L., Pinney, K. G., & Mason, R. P. (2022). Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment. Cancers, 14(17), 4208. https://doi.org/10.3390/cancers14174208

Chicago

Liu, Li, Regan Schuetze, Jeni L. Gerberich, Ramona Lopez, Samuel O. Odutola, Rajendra P. Tanpure, Amanda K. Charlton-Sevcik, et al. 2022. “Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment.” Cancers 14 (17): 4208. doi:10.3390/cancers14174208.